Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sepsis | 21 | 2021 | 3517 | 3.48 | Why? |
| Patient Readmission | 9 | 2021 | 1543 | 2.43 | Why? |
| Shock, Septic | 3 | 2021 | 1313 | 0.82 | Why? |
| Multiple Organ Failure | 2 | 2021 | 1724 | 0.76 | Why? |
| Survivorship | 1 | 2020 | 106 | 0.76 | Why? |
| United States Department of Veterans Affairs | 4 | 2019 | 553 | 0.76 | Why? |
| Reimbursement Mechanisms | 1 | 2018 | 243 | 0.59 | Why? |
| Benchmarking | 1 | 2019 | 627 | 0.57 | Why? |
| Bronchoalveolar Lavage | 1 | 2018 | 603 | 0.53 | Why? |
| Muscle Weakness | 1 | 2017 | 406 | 0.51 | Why? |
| Hospitalization | 12 | 2021 | 54280 | 0.50 | Why? |
| Michigan | 4 | 2021 | 988 | 0.50 | Why? |
| Critical Care | 8 | 2021 | 14081 | 0.47 | Why? |
| Decision Support Systems, Clinical | 1 | 2017 | 551 | 0.47 | Why? |
| Medicare | 6 | 2018 | 1048 | 0.46 | Why? |
| Health Services | 1 | 2018 | 765 | 0.45 | Why? |
| Overweight | 1 | 2018 | 916 | 0.45 | Why? |
| Deglutition Disorders | 1 | 2017 | 481 | 0.43 | Why? |
| Terminal Care | 1 | 2021 | 928 | 0.43 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.43 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.40 | Why? |
| Heart Failure | 3 | 2021 | 6638 | 0.40 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2018 | 861 | 0.39 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.39 | Why? |
| Survivors | 2 | 2017 | 2619 | 0.36 | Why? |
| Hospital Mortality | 10 | 2020 | 22087 | 0.35 | Why? |
| Patient Discharge | 3 | 2021 | 5696 | 0.35 | Why? |
| Critical Illness | 3 | 2020 | 17281 | 0.33 | Why? |
| Veterans | 1 | 2017 | 1131 | 0.32 | Why? |
| Nervous System Diseases | 2 | 2021 | 4092 | 0.30 | Why? |
| Electronic Health Records | 1 | 2019 | 3492 | 0.30 | Why? |
| United States | 13 | 2021 | 46150 | 0.29 | Why? |
| Hospitals | 4 | 2021 | 11793 | 0.28 | Why? |
| Primary Health Care | 2 | 2019 | 4839 | 0.26 | Why? |
| Humans | 46 | 2021 | 930598 | 0.26 | Why? |
| Quality Indicators, Health Care | 2 | 2019 | 580 | 0.25 | Why? |
| Azithromycin | 1 | 2018 | 3943 | 0.25 | Why? |
| Fluid Therapy | 2 | 2018 | 628 | 0.25 | Why? |
| Cohort Studies | 7 | 2021 | 36005 | 0.23 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.23 | Why? |
| Pneumonia | 2 | 2018 | 5652 | 0.21 | Why? |
| Quality of Life | 2 | 2020 | 9820 | 0.20 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.20 | Why? |
| Respiratory Aspiration | 1 | 2018 | 23 | 0.19 | Why? |
| Diagnosis-Related Groups | 1 | 2019 | 167 | 0.18 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.18 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.18 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.18 | Why? |
| Aged | 15 | 2021 | 215776 | 0.17 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.17 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.16 | Why? |
| Anti-Bacterial Agents | 5 | 2021 | 10083 | 0.16 | Why? |
| Vasoconstrictor Agents | 1 | 2021 | 714 | 0.16 | Why? |
| Mandatory Reporting | 1 | 2018 | 140 | 0.16 | Why? |
| Self-Help Groups | 1 | 2018 | 163 | 0.16 | Why? |
| Patients' Rooms | 1 | 2021 | 675 | 0.16 | Why? |
| Time Factors | 6 | 2021 | 31397 | 0.16 | Why? |
| Patient Care Planning | 1 | 2021 | 582 | 0.15 | Why? |
| Endpoint Determination | 1 | 2018 | 344 | 0.15 | Why? |
| Sample Size | 1 | 2018 | 518 | 0.15 | Why? |
| Hospitals, High-Volume | 1 | 2019 | 688 | 0.15 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.14 | Why? |
| Withholding Treatment | 1 | 2021 | 798 | 0.14 | Why? |
| Rehabilitation | 1 | 2020 | 386 | 0.14 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.14 | Why? |
| Return to Work | 1 | 2020 | 579 | 0.13 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.13 | Why? |
| Renal Insufficiency | 1 | 2021 | 810 | 0.13 | Why? |
| Adrenal Cortex Hormones | 2 | 2021 | 6537 | 0.13 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.13 | Why? |
| Acute Disease | 2 | 2017 | 6029 | 0.13 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.12 | Why? |
| Male | 15 | 2021 | 367725 | 0.12 | Why? |
| Terminology as Topic | 1 | 2018 | 546 | 0.12 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.12 | Why? |
| Female | 15 | 2021 | 380317 | 0.12 | Why? |
| Dysbiosis | 1 | 2018 | 685 | 0.12 | Why? |
| Cognition Disorders | 1 | 2018 | 574 | 0.12 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.11 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.11 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.11 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.11 | Why? |
| Coinfection | 2 | 2021 | 6820 | 0.11 | Why? |
| Patient Outcome Assessment | 1 | 2015 | 707 | 0.11 | Why? |
| Emergency Treatment | 1 | 2017 | 719 | 0.11 | Why? |
| Government Regulation | 1 | 2018 | 842 | 0.11 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.11 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.11 | Why? |
| Probiotics | 1 | 2018 | 694 | 0.10 | Why? |
| Pneumonia, Bacterial | 1 | 2018 | 843 | 0.10 | Why? |
| Length of Stay | 2 | 2019 | 11042 | 0.10 | Why? |
| New York | 1 | 2018 | 2488 | 0.10 | Why? |
| Muscle, Skeletal | 1 | 2017 | 915 | 0.10 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Temperature | 1 | 2019 | 2305 | 0.10 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.10 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.09 | Why? |
| Respiratory Tract Diseases | 1 | 2017 | 1061 | 0.09 | Why? |
| England | 1 | 2021 | 5116 | 0.09 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.09 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.09 | Why? |
| Research | 1 | 2021 | 2115 | 0.09 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.08 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.08 | Why? |
| Severity of Illness Index | 4 | 2019 | 48226 | 0.08 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Health Surveys | 1 | 2018 | 2841 | 0.08 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.07 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.06 | Why? |
| Disease Management | 1 | 2021 | 6841 | 0.06 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Mortality | 1 | 2019 | 7132 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.06 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.05 | Why? |
| Intubation, Intratracheal | 1 | 2017 | 3962 | 0.05 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Time-to-Treatment | 1 | 2017 | 5883 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.05 | Why? |
| Nursing Homes | 1 | 2017 | 4155 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Prebiotics | 1 | 2018 | 53 | 0.05 | Why? |
| Adult | 4 | 2021 | 244371 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 6653 | 0.04 | Why? |
| Fee-for-Service Plans | 1 | 2017 | 144 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Comorbidity | 2 | 2018 | 34796 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.04 | Why? |
| Clinical Audit | 1 | 2017 | 204 | 0.04 | Why? |
| Hospitals, Veterans | 1 | 2018 | 229 | 0.04 | Why? |
| Mental Disorders | 1 | 2018 | 6742 | 0.03 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.03 | Why? |
| Fecal Microbiota Transplantation | 1 | 2018 | 372 | 0.03 | Why? |
| Ventilation | 1 | 2021 | 1145 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Hemodynamics | 1 | 2021 | 1562 | 0.03 | Why? |
| Databases, Factual | 2 | 2018 | 6248 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Health Services Research | 1 | 2017 | 756 | 0.03 | Why? |
| California | 1 | 2017 | 2047 | 0.03 | Why? |
| Patient Positioning | 1 | 2021 | 1505 | 0.03 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Delivery of Health Care | 1 | 2015 | 15909 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2021 | 3228 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2017 | 3419 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.01 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Prescott's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(173)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(96)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_